GlaxoSmithKline Plc (GSK) on Thursday said it has offloaded its 5.7 per cent stake in Indian FMCG major Hindustan Unilever for around Rs 25,480 crore.
The company had received the shares as part of the scheme of merger of its subsidiary GlaxoSmithKline Consumer Healthcare Limited (GSK India) with Hindustan Unilever Limited (HUL).
"GSK has, through its subsidiaries GlaxoSmithKline Pte Ltd and Horlicks Limited, today agreed to the sale of 13.37 crore ordinary shares in HUL at a volume-weighted average price of approximately Rs 1,905 per share... Читать дальше...